{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:28Z","timestamp":1791994588388,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T00:00:00Z","timestamp":1701129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515110073"],"award-info":[{"award-number":["2019A1515110073"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515012109"],"award-info":[{"award-number":["2021A1515012109"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515011396"],"award-info":[{"award-number":["2021A1515011396"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172215"],"award-info":[{"award-number":["82172215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072267"],"award-info":[{"award-number":["82072267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Futian District Public Health Research Project","award":["FTWS2020008"],"award-info":[{"award-number":["FTWS2020008"]}]},{"name":"Shenzhen Futian District Public Health Research Project","award":["FTWS2020017"],"award-info":[{"award-number":["FTWS2020017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As a histone methyltransferase, suppressor of variegation 3\u20139 homolog 1 (SUV39H1) plays an important role in the occurrence and development of cancer. To explore the mechanism and biological function of SUV39H1 in hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) can gain an insight into the pathogenesis of HBV-HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The effect of HBV infection on SUV39H1 in hepatoma cells was detected. CCK-8, colony growth assay and wound healing assay were used to assess the proliferation and migration of HBV-positive hepatoma cells. RNA sequencing (RNA-seq) was applied to find differential genes and enriched pathways. The serum SUV39H1 level in HBV-HCC patients was detected and its correlation with clinical indicators was analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SUV39H1 was increased by HBV infection and promoted the proliferation and migration of hepatoma cells. SUV39H1 could upregulate the expression of mitochondrial oxidative phosphorylation (OXPHOS) pathway-related genes. OXPHOS pathway inhibitors could reduce the capacity of proliferation and migration of hepatoma cells after overexpressing SUV39H1. Serum SUV39H1 levels were higher in chronic hepatitis B (CHB) patients than in healthy controls and higher in HBV-HCC patients than in CHB patients. In the diagnosis of HCC, the predictive value of SUV39H1 combined with alpha-fetoprotein (AFP) was better than that of AFP alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SUV39H1 is regulated by HBV infection and promotes the proliferation and migration of hepatoma cells by targeting OXPHOS pathway. It indicates that SUV39H1 may be a new biomarker of the diagnosis of HCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-023-11633-4","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T10:02:17Z","timestamp":1701165737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Yanping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwen","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xumeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixia","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,28]]},"reference":[{"issue":"3","key":"11633_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"11633_CR2","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/hep.32447","volume":"75","author":"F Foerster","year":"2022","unstructured":"Foerster F, Gairing SJ, Ilyas SI, Galle PR. Emerging immunotherapy for HCC: a guide for hepatologists. Hepatology. 2022;75(6):1604\u201326.","journal-title":"Hepatology"},{"issue":"2","key":"11633_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of Hepatocellular Carcinoma. Gastroenterology. 2019;156(2):477\u2013491e471.","journal-title":"Gastroenterology"},{"issue":"10127","key":"11633_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301\u201314.","journal-title":"Lancet"},{"issue":"6","key":"11633_CR5","doi-asserted-by":"publisher","first-page":"100167","DOI":"10.1016\/j.jhepr.2020.100167","volume":"2","author":"MG Fern\u00e1ndez-Barrena","year":"2020","unstructured":"Fern\u00e1ndez-Barrena MG, Arechederra M, Colyn L, Berasain C, Avila MA. Epigenetics in hepatocellular carcinoma development and therapy: the tip of the iceberg. JHEP Rep. 2020;2(6):100167.","journal-title":"JHEP Rep"},{"issue":"6796","key":"11633_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/35020506","volume":"406","author":"S Rea","year":"2000","unstructured":"Rea S, Eisenhaber F, O\u2019Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000;406(6796):593\u20139.","journal-title":"Nature"},{"key":"11633_CR7","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/ncomms2885","volume":"4","author":"B Liu","year":"2013","unstructured":"Liu B, Wang Z, Zhang L, Ghosh S, Zheng H, Zhou Z. Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model. Nat Commun. 2013;4:1868.","journal-title":"Nat Commun"},{"issue":"2","key":"11633_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.yexcr.2019.02.010","volume":"378","author":"C Rodrigues","year":"2019","unstructured":"Rodrigues C, Pattabiraman C, Vijaykumar A, Arora R, Narayana SM, Kumar RV, Notani D, Varga-Weisz P, Krishna S. A SUV39H1-low chromatin state characterises and promotes migratory properties of Cervical cancer cells. Exp Cell Res. 2019;378(2):206\u201316.","journal-title":"Exp Cell Res"},{"issue":"2","key":"11633_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/nar\/gkp991","volume":"38","author":"YJ Yang","year":"2010","unstructured":"Yang YJ, Han JW, Youn HD, Cho EJ. The Tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Res. 2010;38(2):382\u201390.","journal-title":"Nucleic Acids Res"},{"issue":"50","key":"11633_CR10","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1038\/s41388-020-01495-6","volume":"39","author":"Y Chu","year":"2020","unstructured":"Chu Y, Chen Y, Guo H, Li M, Wang B, Shi D, Cheng X, Guan J, Wang X, Xue C, et al. SUV39H1 regulates the progression of MLL-AF9-induced acute Myeloid Leukemia. Oncogene. 2020;39(50):7239\u201352.","journal-title":"Oncogene"},{"key":"11633_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.canlet.2020.02.004","volume":"476","author":"C Lu","year":"2020","unstructured":"Lu C, Klement JD, Yang D, Albers T, Lebedyeva IO, Waller JL, Liu K. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote Tumor growth. Cancer Lett. 2020;476:87\u201396.","journal-title":"Cancer Lett"},{"issue":"10","key":"11633_CR12","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1096\/fj.201700645RRRRR","volume":"32","author":"G Kim","year":"2018","unstructured":"Kim G, Kim JY, Lim SC, Lee KY, Kim O, Choi HS. SUV39H1\/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and Melanoma development. Faseb j. 2018;32(10):5647\u201360.","journal-title":"Faseb j"},{"issue":"2","key":"11633_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ijc.28985","volume":"136","author":"T Chiba","year":"2015","unstructured":"Chiba T, Saito T, Yuki K, Zen Y, Koide S, Kanogawa N, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, et al. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Int J Cancer. 2015;136(2):289\u201398.","journal-title":"Int J Cancer"},{"issue":"12","key":"11633_CR14","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/infdis\/jiaa317","volume":"222","author":"Y Takeuchi","year":"2020","unstructured":"Takeuchi Y, Tsuge M, Tsushima K, Suehiro Y, Fujino H, Ono A, Yamauchi M, Makokha GN, Nakahara T, Murakami E, et al. Signal activation of Hepatitis B Virus-Related Hepatocarcinogenesis by Up-regulation of SUV39h1. J Infect Dis. 2020;222(12):2061\u201370.","journal-title":"J Infect Dis"},{"issue":"1","key":"11633_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41389-023-00491-1","volume":"12","author":"S Guo","year":"2023","unstructured":"Guo S, Li F, Liang Y, Zheng Y, Mo Y, Zhao D, Jiang Z, Cui M, Qi L, Chen J, et al. AIFM2 promotes hepatocellular carcinoma Metastasis by enhancing mitochondrial biogenesis through activation of SIRT1\/PGC-1\u03b1 signaling. Oncogenesis. 2023;12(1):46.","journal-title":"Oncogenesis"},{"issue":"7168","key":"11633_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature06268","volume":"450","author":"A Vaquero","year":"2007","unstructured":"Vaquero A, Scher M, Erdjument-Bromage H, Tempst P, Serrano L, Reinberg D. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation. Nature. 2007;450(7168):440\u20134.","journal-title":"Nature"},{"issue":"10","key":"11633_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"11633_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41467-020-15237-5","volume":"11","author":"B Sch\u00f6pf","year":"2020","unstructured":"Sch\u00f6pf B, Weissensteiner H, Sch\u00e4fer G, Fazzini F, Charoentong P, Naschberger A, Rupp B, Fendt L, Bukur V, Giese I, et al. OXPHOS remodeling in high-grade Prostate cancer involves mtDNA mutations and increased succinate oxidation. Nat Commun. 2020;11(1):1487.","journal-title":"Nat Commun"},{"issue":"1","key":"11633_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2019.06.009","volume":"26","author":"KG Roth","year":"2020","unstructured":"Roth KG, Mambetsariev I, Kulkarni P, Salgia R. The Mitochondrion as an emerging therapeutic target in Cancer. Trends Mol Med. 2020;26(1):119\u201334.","journal-title":"Trends Mol Med"},{"issue":"4455","key":"11633_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1126\/science.6248960","volume":"209","author":"BB Knowles","year":"1980","unstructured":"Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and Hepatitis B surface antigen. Science. 1980;209(4455):497\u20139.","journal-title":"Science"},{"key":"11633_CR21","doi-asserted-by":"publisher","first-page":"1052917","DOI":"10.3389\/fmicb.2022.1052917","volume":"13","author":"X Yu","year":"2022","unstructured":"Yu X, Chen Y, Cui L, Yang K, Wang X, Lei L, Zhang Y, Kong X, Lao W, Li Z, et al. CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic Hepatitis B. Front Microbiol. 2022;13:1052917.","journal-title":"Front Microbiol"},{"issue":"1","key":"11633_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"11633_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351.","journal-title":"Protein Sci"},{"issue":"D1","key":"11633_CR24","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51(D1):D587\u2013d592.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"11633_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3201\/eid2305.161477","volume":"23","author":"F Cui","year":"2017","unstructured":"Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, et al. Prevention of Chronic Hepatitis B after 3 decades of escalating Vaccination Policy, China. Emerg Infect Dis. 2017;23(5):765\u201372.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"11633_CR26","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, Jin L, Zhang T, Chen X. The trends in incidence of primary Liver cancer caused by specific etiologies: results from the global burden of Disease Study 2016 and implications for Liver cancer prevention. J Hepatol. 2019;70(4):674\u201383.","journal-title":"J Hepatol"},{"key":"11633_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/JHC.S307962","volume":"8","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Han Q, Zhao H, Zhang J. The mechanisms of HBV-Induced Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:435\u201350.","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"11633_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12250-015-3582-7","volume":"30","author":"Y Tian","year":"2015","unstructured":"Tian Y, Ou JH. Genetic and epigenetic alterations in Hepatitis B virus-associated hepatocellular carcinoma. Virol Sin. 2015;30(2):85\u201391.","journal-title":"Virol Sin"},{"issue":"1","key":"11633_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-017-0657-7","volume":"41","author":"J Wang","year":"2018","unstructured":"Wang J, Yan W, Peng X, Jiang Y, He L, Peng Y, Chen X, Ye M, Zhuo H. Functional role of SUV39H1 in human renal tubular epithelial cells under high-glucose ambiance. Inflammation. 2018;41(1):1\u201310.","journal-title":"Inflammation"},{"issue":"1","key":"11633_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13148-019-0706-1","volume":"11","author":"J Li","year":"2019","unstructured":"Li J, Yang G, Liu S, Wang L, Liang Z, Zhang H. Suv39h1 promotes facet joint chondrocyte proliferation by targeting miR-15a\/Bcl2 in idiopathic scoliosis patients. Clin Epigenetics. 2019;11(1):107.","journal-title":"Clin Epigenetics"},{"key":"11633_CR31","doi-asserted-by":"publisher","first-page":"114772","DOI":"10.1016\/j.taap.2019.114772","volume":"384","author":"Y Miao","year":"2019","unstructured":"Miao Y, Lv Q, Qiao S, Yang L, Tao Y, Yan W, Wang P, Cao N, Dai Y, Wei Z. Alpinetin improves intestinal barrier homeostasis via regulating AhR\/suv39h1\/TSC2\/mTORC1\/autophagy pathway. Toxicol Appl Pharmacol. 2019;384:114772.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"11633_CR32","doi-asserted-by":"publisher","first-page":"188498","DOI":"10.1016\/j.bbcan.2020.188498","volume":"1875","author":"N Saha","year":"2021","unstructured":"Saha N, Muntean AG. Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188498.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"11633_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.apsb.2020.09.015","volume":"11","author":"J Wang","year":"2021","unstructured":"Wang J, Yin X, He W, Xue W, Zhang J, Huang Y. SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis. Acta Pharm Sin B. 2021;11(2):406\u201319.","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"11633_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"11633_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","volume":"3","author":"PJ Burke","year":"2017","unstructured":"Burke PJ. Mitochondria, Bioenergetics and apoptosis in Cancer. Trends Cancer. 2017;3(12):857\u201370.","journal-title":"Trends Cancer"},{"issue":"5","key":"11633_CR36","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1172\/JCI82661","volume":"126","author":"G Zhang","year":"2016","unstructured":"Zhang G, Frederick DT, Wu L, Wei Z, Krepler C, Srinivasan S, Chae YC, Xu X, Choi H, Dimwamwa E, et al. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest. 2016;126(5):1834\u201356.","journal-title":"J Clin Invest"},{"key":"11633_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fphar.2019.00203","volume":"10","author":"P Jagust","year":"2019","unstructured":"Jagust P, de Lux\u00e1n-Delgado B, Parejo-Alonso B, Sancho P. Metabolism-based therapeutic strategies targeting Cancer Stem cells. Front Pharmacol. 2019;10:203.","journal-title":"Front Pharmacol"},{"key":"11633_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.omtn.2020.09.040","volume":"23","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhou L, Li H, Sun T, Wen X, Li X, Meng Y, Li Y, Liu M, Liu S, et al. Nuclear-encoded lncRNA MALAT1 epigenetically controls metabolic reprogramming in HCC cells through the Mitophagy Pathway. Mol Ther Nucleic Acids. 2021;23:264\u201376.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"11633_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41419-020-2528-7","volume":"11","author":"H Chang","year":"2020","unstructured":"Chang H, Li J, Qu K, Wan Y, Liu S, Zheng W, Zhang Z, Liu C. CRIF1 overexpression facilitates Tumor growth and Metastasis through inducing ROS\/NF\u03baB pathway in hepatocellular carcinoma. Cell Death Dis. 2020;11(5):332.","journal-title":"Cell Death Dis"},{"issue":"6","key":"11633_CR40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.dld.2017.01.146","volume":"49","author":"L Turcios","year":"2017","unstructured":"Turcios L, Vilchez V, Acosta LF, Poyil P, Butterfield DA, Mitov M, Marti F, Gedaly R. Sorafenib and FH535 in combination act synergistically on hepatocellular carcinoma by targeting cell bioenergetics and mitochondrial function. Dig Liver Dis. 2017;49(6):697\u2013704.","journal-title":"Dig Liver Dis"},{"issue":"31","key":"11633_CR41","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.18632\/oncotarget.27680","volume":"11","author":"L Turcios","year":"2020","unstructured":"Turcios L, Marti F, Watt DS, Kril LM, Khurana A, Chapelin F, Liu C, Zwischenberger JB, Evers BM, Gedaly R. Mitochondrial uncoupling and the disruption of the metabolic network in hepatocellular carcinoma. Oncotarget. 2020;11(31):3013\u201324.","journal-title":"Oncotarget"},{"issue":"37","key":"11633_CR42","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","volume":"21","author":"N Tsuchiya","year":"2015","unstructured":"Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015;21(37):10573\u201383.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"11633_CR43","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","volume":"34","author":"F Trevisani","year":"2001","unstructured":"Trevisani F, D\u2019Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic Liver Disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001;34(4):570\u20135.","journal-title":"J Hepatol"},{"issue":"2","key":"11633_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/j.gastro.2009.10.031","volume":"138","author":"AS Lok","year":"2010","unstructured":"Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, et al. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2010;138(2):493\u2013502.","journal-title":"Gastroenterology"},{"issue":"3","key":"11633_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/ijms21030949","volume":"21","author":"I Baudi","year":"2020","unstructured":"Baudi I, Inoue T, Tanaka Y. Novel biomarkers of Hepatitis B and Hepatocellular Carcinoma: clinical significance of HBcrAg and M2BPGi. Int J Mol Sci. 2020;21(3):949.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"11633_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/hep4.1321","volume":"3","author":"T Jun","year":"2019","unstructured":"Jun T, Hsu YC, Ogawa S, Huang YT, Yeh ML, Tseng CH, Huang CF, Tai CM, Dai CY, Huang JF, et al. Mac-2 binding protein glycosylation isomer as a Hepatocellular Carcinoma Marker in patients with chronic Hepatitis B or C Infection. Hepatol Commun. 2019;3(4):493\u2013503.","journal-title":"Hepatol Commun"},{"key":"11633_CR47","first-page":"864894","volume":"2014","author":"H Wang","year":"2014","unstructured":"Wang H, Hou L, Li A, Duan Y, Gao H, Song X. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int. 2014;2014:864894.","journal-title":"Biomed Res Int"},{"issue":"3","key":"11633_CR48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1515\/cclm-2017-0327","volume":"56","author":"H Xu","year":"2018","unstructured":"Xu H, Dong X, Chen Y, Wang X. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma. Clin Chem Lab Med. 2018;56(3):479\u201384.","journal-title":"Clin Chem Lab Med"},{"issue":"22","key":"11633_CR49","doi-asserted-by":"publisher","first-page":"650","DOI":"10.21037\/atm.2019.10.78","volume":"7","author":"D Wang","year":"2019","unstructured":"Wang D, Hu X, Long G, Xiao L, Wang ZM, Zhou LD. The clinical value of total plasma cell-free DNA in Hepatitis B virus-related hepatocellular carcinoma. Ann Transl Med. 2019;7(22):650.","journal-title":"Ann Transl Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-023-11633-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-023-11633-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T10:03:15Z","timestamp":1701165795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-023-11633-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["11633"],"URL":"https:\/\/doi.org\/10.1186\/s12885-023-11633-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,28]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been performed in accordance with the Declaration of Helsinki and was approved by the Research Ethics Board of the Eighth Affiliated Hospital of Sun Yat-sen University (Approval number: ZB-KYIRB-AF\/SC-06\/01.0), and written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1159"}}